My lab is interested in translational research with a focus on pulmonary diseases in immune compromised persons. Using an airway transplant model, we have identified modifiable risk factors that may promote pathogen invasion in lung transplant recipients. We hope that these discoveries will lead to novel treatments for these prevalent infections. I am also the director of the Lung Graft Versus Host Disease clinic. In this clinic we are developing imaging methods for the earlier diagnosis of lung GVHD and conducting a phase II randomized controlled trial to study Pirfenidone for treatment of bronchiolitis obliterans syndrome after hematopoietic cell transplant.